Virginia drug substance facility (Rivanna Futures)
AstraZeneca, Charlottesville area, Albemarle County, Virginia
Virginia drug substance facility (Rivanna Futures) in Charlottesville area, Virginia is AstraZeneca’s plant for drug substance for metabolic/weight portfolio; ADC scope added. Status: under construction as of October 9, 2025 (groundbreaking). AstraZeneca announced $4.5 billion and 600 jobs. Primary source: astrazeneca-us.com, checked November 1, 2026.
- Status
- Under construction
- Announced investment
- $4.5 billion
- Announced jobs
- 600
- Industry
- Pharmaceuticals
- Sheet
- VA-03
- Revised
- November 1, 2026
Status timeline
- Announcedastrazeneca-us.com
- Groundbreakingastrazeneca.com
Filled dots are confirmed by a company, state, SEC or federal source. Dashed dots come from news reports only. Investment and job figures are as announced, not achieved.
Plant facts
| Company | AstraZeneca |
|---|---|
| Plant | Virginia drug substance facility (Rivanna Futures) |
| Location | Charlottesville area, Albemarle County, Virginia |
| Industry | Pharmaceuticals |
| Product | Drug substance for metabolic/weight portfolio; ADC scope added |
| Announced investment | $4.5 billionRaised from earlier proposed amount by $500M at groundbreaking |
| Announced jobs | 600 |
| Last checked | November 1, 2026 |
Sources
- AstraZeneca $50B US investment plan (company release, astrazeneca-us.com, checked November 1, 2026)
- AstraZeneca raises Virginia facility to $4.5B (company release, astrazeneca.com, checked November 1, 2026)
Something changed? Send a correction with a link and we'll recheck it.